Tightly regulated Doxycycline (Dox)-inducible lentiviral vectors for human myeloprotective gene therapy: in vitro and CD34+ - xenotransplant studies

被引:0
|
作者
Lachmann, N. [1 ,2 ]
Hillje, R. [1 ,2 ]
Kuhn, A. [1 ,2 ]
Brennig, S. [1 ,2 ]
Dahlmann, J. [3 ]
Heinz, N. [2 ]
Gruh, I. [3 ]
Schiedlmeier, B. [2 ,3 ]
Baum, C. [2 ]
Moritz, T. [1 ,2 ]
机构
[1] Hannover Med Sch, REBIRTH Cluster Excellence, Reprogramming & Gene Therapy Grp, Hannover, Germany
[2] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany
[3] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, Hannover, Germany
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A71 / A72
页数:2
相关论文
共 50 条
  • [11] Optimized Lentiviral Transduction Process for ex vivo CD34+ Hematopoietic Stem Cell Gene Therapy Drug Product Manufacture
    Elavazhagan, S.
    Masdeu, M. del Mar
    Zabinski, T.
    Enjalbert, F.
    Pennucci, V.
    Rana, B.
    Whiting, C.
    Recchi, C.
    Heal, P.
    Thrasher, A.
    Carbonaro-Sarracino, D. A.
    Wolfe, J.
    Gaspar, H. B.
    Sagoo, P.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A112 - A113
  • [12] Restoration of ex vivo telomere homeostasis in dyskeratosis congenita-like CD34+ cells through lentiviral gene therapy
    Llorente-Arroyo, D.
    Meza, N. W.
    Lozano, M. L.
    Sastre, L.
    Perona, R.
    Bueren, J. A.
    Guenechea, G.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A299 - A299
  • [13] Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors
    Douglas, J
    Kelly, P
    Evans, JT
    Garcia, JV
    HUMAN GENE THERAPY, 1999, 10 (06) : 935 - 945
  • [14] Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells
    Zhang, Yanyan
    Wittner, Monika
    Bouamar, Hakim
    Jarrier, Peggy
    Vainchenker, William
    Louache, Fawzia
    STEM CELLS, 2007, 25 (01) : 211 - 219
  • [15] Gene transfer into human cord blood-derived CD34+ cells by adeno-associated viral vectors
    Schuhmann, Natascha K.
    Pozzoli, Ombretta
    Sallach, Jessica
    Huber, Anke
    Avitabile, Daniele
    Perabo, Luca
    Rappl, Gunter
    Capogrossi, Maurizio C.
    Hallek, Michael
    Pesce, Maurizio
    Buening, Hildegard
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : 707 - 717
  • [16] Transduction kinetics of non-human primate immunoselected CD34+ cells using retroviral and lentiviral vectors that express the green fluorescent protein.
    Donahue, RE
    Rowe, TK
    Sorrentino, BP
    Hawley, RG
    An, DS
    Chen, ISY
    Wersto, RP
    BLOOD, 1998, 92 (10) : 376B - 376B
  • [17] MDR1 gene transfer using a lentiviral SIN vector confers radioprotection to human CD34+ hematopoietic progenitor cells
    Maier, Patrick
    Herskind, Carsten
    Fleckenstein, Katharina
    Spier, Isabel
    Laufs, Stephanie
    Zeller, W. Jens
    Fruehauf, Stefan
    Wenz, Frederik
    RADIATION RESEARCH, 2008, 169 (03) : 301 - 310
  • [18] Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
    Radtke, Stefan
    Pande, Dnyanada
    Cui, Margaret
    Perez, Anai M.
    Chan, Yan-Yi
    Enstrom, Mark
    Schmuck, Stefanie
    Berger, Andrew
    Eunson, Tom
    Adair, Jennifer E.
    Kiem, Hans-Peter
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 679 - 691
  • [19] TRIM5α Variations Influence Transduction Efficiency With Lentiviral Vectors in Both Human and Rhesus CD34+Cells In Vitro and In Vivo
    Evans, Molly E.
    Kumkhaek, Chutima
    Hsieh, Matthew M.
    Donahue, Robert E.
    Tisdale, John F.
    Uchida, Naoya
    MOLECULAR THERAPY, 2014, 22 (02) : 348 - 358
  • [20] Lenti-viral based gene transfer vectors efficiently transduce human cord blood CD34+/CD38- cells.
    Kelly, PF
    Evans, JT
    Douglas, JL
    O'Neill, E
    Garcia, JV
    BLOOD, 1998, 92 (10) : 149A - 149A